Expression and Implication of Toll-like Receptors TLR2, TLR4 and TLR9 in Colonic Mucosa of Patients with Ulcerative Colitis

Overview

Journal J Huazhong Univ Sci Technolog Med Sci

Specialty General Medicine

Date 2014 Oct 17

PMID 25318894

Citations 18

Authors

Yan Tan

Kai-Fang Zou

Wei Qian

Sheng Chen

Xiao-Hua Hou

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors (TLRs) family may play important roles in inflammatory bowel disease. This study examined the expression of TLR2, TLR4 and TLR9 in the colonic tissues of patients with ulcerative colitis (UC) and explored their roles in the pathogenesis of UC. Colonic biopsies were taken from the colon of 30 patients with mild or moderate UC (at active phase) and 10 healthy controls during colonoscopy. TLR2, TLR4 and TLR9 protein expression levels were immunohistochemically detected. The mRNA expression levels of TLR2, TLR4 and TLR9 were assessed by reverse transcription polymerase chain reaction (RT-PCR). The disease activity index (DAI), colonoscopic and histologic grades and fecal microbial flora were determined. Histological examination showed that the intestinal mucous membrane of UC patients underwent acute inflammation changes. Immunohistochemistry exhibited that the expression levels of TLR2, TLR4 and TLR9 in colon epithelia and inflammatory cells were higher in UC patients than in control group (P<0.01). The mRNA expression levels of TLR2, TLR4 and TLR9 were increased in UC patients but were not detected in the normal controls. Expression levels of TLR2, TLR4 and TLR9 were positively correlated, and bore close correlation with DAI, colonoscopic and histologic grades and fecal microbial flora. An important mechanism of UC might be that abnormal activation of mucosal immunity by intestinal dysbacteriosis caused dysregulation of TLRS that mediates innate immunity.

Citing Articles

Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut-brain axis.

Morshedbak M, Rahimi K, Tabandeh M Heliyon. 2025; 11(3):e42430.

PMID: 39995913 PMC: 11848074. DOI: 10.1016/j.heliyon.2025.e42430.

Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis.

Chen L, Zhang L, Hua H, Liu L, Mao Y, Wang R Immun Inflamm Dis. 2024; 12(7):e1356.

PMID: 39073297 PMC: 11284964. DOI: 10.1002/iid3.1356.

Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway.

Wen X, Xie R, Wang H, Zhang M, He L, Zhang M World J Gastroenterol. 2023; 29(30):4657-4670.

PMID: 37662857 PMC: 10472902. DOI: 10.3748/wjg.v29.i30.4657.

Inhibitory Effects of Chlorogenic Acid Containing Green Coffee Bean Extract on Lipopolysaccharide-Induced Inflammatory Responses and Progression of Colon Cancer Cell Line.

Panyathep A, Punturee K, Chewonarin T Foods. 2023; 12(14).

PMID: 37509740 PMC: 10378980. DOI: 10.3390/foods12142648.

Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring.

Asadzadeh-Aghdaei H, Rejali L, Nourian M, Chaleshi V, Zamani N, Baradaran-Ghavami S Adv Biomed Res. 2023; 12:54.

PMID: 37057238 PMC: 10086669. DOI: 10.4103/abr.abr_24_22.

References

Sartor R . Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(7):390-407. DOI: 10.1038/ncpgasthep0528. View

Gan H, OuYang Q, Jia D, Xia Q . [Activation of nuclear factor-kappaB and its relationship with cytokine gene expression in colonic mucosa of ulcerative colitis patients]. Zhonghua Nei Ke Za Zhi. 2002; 41(4):252-5. View

Bocker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U . Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis. 2002; 18(1):25-32. DOI: 10.1007/s00384-002-0415-6. View

Kornbluth A, Sachar D . Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004; 99(7):1371-85. DOI: 10.1111/j.1572-0241.2004.40036.x. View

Lenoir C, Sapin C, Broquet A, Jouniaux A, Bardin S, Gasnereau I . MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells. Life Sci. 2008; 82(9-10):519-28. DOI: 10.1016/j.lfs.2007.12.007. View

Ewaschuk J, Backer J, Churchill T, Obermeier F, Krause D, Madsen K . Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun. 2007; 75(5):2572-9. PMC: 1865769. DOI: 10.1128/IAI.01662-06. View

Abreu M, Vora P, Faure E, Thomas L, Arnold E, Arditi M . Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol. 2001; 167(3):1609-16. DOI: 10.4049/jimmunol.167.3.1609. View

Fuse K, Katakura K, Sakamoto N, Ohira H . Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients. World J Gastroenterol. 2010; 16(46):5815-21. PMC: 3001972. DOI: 10.3748/wjg.v16.i46.5815. View

Abreu M . Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010; 10(2):131-44. DOI: 10.1038/nri2707. View

10.

Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

11.

Drexler S, Foxwell B . The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2009; 42(4):506-18. DOI: 10.1016/j.biocel.2009.10.009. View

12.

Chow D, Leong R, Tsoi K, Ng S, Leung W, Wu J . Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009; 104(3):647-54. DOI: 10.1038/ajg.2008.74. View

13.

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

14.

Lange N, Zhou X, Lasky-Su J, Himes B, Lazarus R, Soto-Quiros M . Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet. 2011; 12:26. PMC: 3048492. DOI: 10.1186/1471-2350-12-26. View

15.

Xavier R, Podolsky D . Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. DOI: 10.1038/nature06005. View

16.

Pullan R, Rhodes J, Ganesh S, Mani V, Morris J, Williams G . Transdermal nicotine for active ulcerative colitis. N Engl J Med. 1994; 330(12):811-5. DOI: 10.1056/NEJM199403243301202. View

17.

Sanchez-Munoz F, Fonseca-Camarillo G, Villeda-Ramirez M, Miranda-Perez E, Mendivil E, Barreto-Zuniga R . Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis. BMC Gastroenterol. 2011; 11:138. PMC: 3287145. DOI: 10.1186/1471-230X-11-138. View

18.

Moynagh P . TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005; 26(9):469-76. DOI: 10.1016/j.it.2005.06.009. View

19.

Hall J, Bouladoux N, Sun C, Wohlfert E, Blank R, Zhu Q . Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity. 2008; 29(4):637-49. PMC: 2712925. DOI: 10.1016/j.immuni.2008.08.009. View

20.

Ulevitch R . Toll gates for pathogen selection. Nature. 1999; 401(6755):755-6. DOI: 10.1038/44490. View